注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Mainz Biomed NV是一家德国的分子遗传学癌症诊断公司。该公司经营一个部门,即基因诊断检测部门。其产品组合包括各种产品和候选产品,例如结肠直肠癌(CRC)筛查粪便 DNA(脱氧核糖核酸)测试产品ColoAlert、用于检测胰腺癌的粪便筛查测试产品PancAlert及基于分子遗传学检测环境中病原体的平台技术GenoStrip。该公司与 Exact Sciences、Epigenomics AG、Novigenix SA、GRAIL, Inc.和Agena Biosciences Inc.展开竞争。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Soren Thestrup-Nielsen | - | 2021 | Member of Strategic Advisory Board |
Rainer Metzger | - | 2022 | Member of Strategic Advisory Board |
D. Kim Turgeon | - | 2022 | Member of Medical Advisory Board |
Michele Pedrocchi | - | 2022 | Member of Strategic Advisory Board |
Douglas K. Rex | - | 2022 | Member of Medical Advisory Board |
Timothy Cragin Wang | - | 2022 | Member of Medical Advisory Board |
Alberto Libanori | 33 | 2021 | Independent Non-Executive Director |
Hans Johan Hekland | 65 | 2021 | Independent Non-Executive Director |
Nicole Holden | 49 | 2021 | Independent Non-Executive Director |
Heinrich Dreismann | 70 | 2021 | Independent Non-Executive Chairman |
Gregory J. Tibbitts | 56 | 2022 | Independent Non-Executive Director |
Nicole Holden | 50 | 2021 | Independent Non-Executive Director |
Guido Baechler | 59 | 2021 | CEO & Executive Director |
Moritz Eidens | 40 | 2008 | Chief Science Officer & Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核